In summary, our findings suggest that EFE inhibited the production of inflammatory mediators by down-regulating the activation of the JAK-STAT and MAPK signaling pathways in keratinocytes and alleviating AD symptoms in vivo. This evidence concerns the gene SOAT1 and Alzheimer disease.